AIGENSYN (Gensyn) fluctuates 86.9% in 24 hours: Binance spot listing expectations trigger sharp pump and correction
Bitget Pulse2026/05/14 22:03Volatility Summary
In the past 24 hours, the price of AIGENSYN rebounded from a low of $0.02834 to a high of $0.052952, with the current quote at $0.039153, resulting in a price swing of up to 86.9%. The 24-hour trading volume expanded significantly, with spot trading volume around $25.57 million and futures trading volume reaching $576 million. There are apparent signs of net capital inflow, with long positions dominating.
Brief Analysis of Market Movement Reasons
- Binance announced it will list AIGENSYN/USDT, AIGENSYN/USDC, and AIGENSYN/TRY spot pairs at 13:00 (UTC) on 2026-05-14, with a Seed Tag label. This directly caused the price to pump from a low of $0.0273 to a peak of $0.0508.
- The listing time was temporarily postponed to 15:00 (UTC), leading to a rapid pullback after the peak. Futures trading volume surged to over $3 billion, with active leverage signals.
Market Opinions and Outlook
Market sentiment remains largely optimistic, with most trade signals on platform X recommending long positions, targeting the $0.0405–0.047 range. The community views the Binance listing as a positive catalyst, but there is caution regarding the Seed Tag's high-risk warning and potential sell pressure post-listing. The market may continue to fluctuate and should monitor the actual execution of the listing and capital flow.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Nebius Q3 results exceed expectations, capital expenditure rises to $27 billion, ARR target postponed, stock falls over 14% pre-market | Earnings Report Insights
Nebius reported Q3 revenue of $981 million (a year-on-year increase of 571%) and adjusted EBITDA of $466 million, both exceeding expectations. However, the company delayed and lowered its guidance for annual recurring revenue (ARR), stating that it is no longer applicable. Additionally, it significantly raised its 2026 capital expenditure target to $27 billion, with projections to further increase to $40 billion to $45 billion in 2027. The stock price plummeted more than 14% in pre-market trading.